Navigation Links
Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'
Date:9/22/2008

ever on a positive note, 76 percent regularly or occasionally get annual check-ups, and 79 percent have their blood pressure or cholesterol regularly or occasionally checked.

Risk of Cardiovascular Disease and Awareness of Aspirin Benefits

Americans tend to rate themselves as somewhat or very knowledgeable about the risk factors associated with heart attacks (83 percent) and strokes (74 percent). Survey respondents also were knowledgeable, having heard or read about, the benefits of aspirin for protecting against another heart attack (94 percent) or stroke (75 percent), and helping save your life if taken during a heart attack (82 percent).

Among the group of patients identified as being at elevated CV risk, 50 percent had spoken with their physician or healthcare professional about taking low-dose aspirin for preventing heart attack or stroke, were advised to take it, and to take it regularly. But, surprisingly, 20 percent of those at elevated risk had never discussed the benefits of low-dose aspirin with a healthcare provider.

Furthermore, among all survey respondents who had spoken with their physicians and been advised to take aspirin (36 percent), about one-sixth were not currently taking it. The most common reasons cited for not following their doctor's orders suggested patients were in denial about their need for aspirin, or simply were forgetful. Specifically, 26 percent of these respondents felt they didn't really need it, 37 percent cited forgetfulness, and 37 percent cited no particular reason.

"While this survey indicates broad knowledge about the benefits of taking low-dose aspirin, aspirin continues to be underutilized by doctors and patients. This is an important problem that must be addressed," said Dr. Nieca Goldberg. "Doctors and patients need to work more closely together to ensure they're having a meaningful dialogue about the role of aspirin in preventing cardiovascular events."

The cornerstone role of a
'/>"/>

SOURCE Bayer Consumer Care
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
9. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
10. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
11. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Drug Discovery Technologies - A G... ,, http://www.reportlinker.com/p0164246/Drug-...-Trends--Opportunities.html ,, Drug discovery ...y pharmaceutical company,s business strategy. Ther...
(Date:12/2/2009)...c. 2 Peregrine Pharmaceu...etion of patient enrollment in a dose confirmation...ith relapsed glioblastoma multiforme (GBM), the de...d monoclonal antibody linked to a radioisotope bei... Cotara specifically targets cells at the center ...
(Date:12/2/2009)...therlands, December 2 Pepscan Hold...y focusing on protein mimicking,technology for the... that it,has appointed Wim E.M. Mol, Ph.D. as new ...e responsible for all of Pepscans corporate functi...tion of the company. He brings to,Pepscan more tha...
(Date:12/2/2009)... 2 S*BIO Pte Ltd today announced d..., SB1518, at The American Society of Hematology 51..., Data will be presented on the clinical result... detailing its safety, tolerability and pharmacoki...ls ranging from 100 to 600 mg. These doses were ad...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...evelopment, Biomarker Identification ..., Oct. 10 MultiCell,Technologies, Inc. (OTC Bulle...ve license and technology purchase agreement with ... Company,s Fa2N-4 immortalized,adult human liver c...and has agreed to purchase,certain inventory and e...
...herapeutics Corporation (Nasdaq: TARG ) today ann...of 5,750,000 shares of its common stock at a price...res are being offered by,Targanta. Targanta has gr...ase up to an additional 862,500 shares of common s...ing discounts and commissions, to cover,over-allot...
...efits of Unsaturated Fatty Acids in ... 10 Amarin Corporation plc,(NASDAQ: AMRN ) today...development strategy to capitalize on the known th...ardiovascular disease. Amarin plans to utilize,its...e to develop a series,of products targeting the va...
Other Biology Technology:MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 2MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 3Targanta Therapeutics Announces Pricing of its Initial Public Offering 2Amarin Announces Initiation of Cardiovascular Development Strategy 2Amarin Announces Initiation of Cardiovascular Development Strategy 3Amarin Announces Initiation of Cardiovascular Development Strategy 4Amarin Announces Initiation of Cardiovascular Development Strategy 5
(Date:12/3/2009)...els that repels grime and dirt? Expanded battery s...el Aviv University research, just published in Na...sembling peptides at the nano-scale level that cou... a few years. , Operating in the range of 100 na...en smaller, graduate student Lihi Adler-Abramovich...
(Date:12/3/2009)...nality change in warmer water, according to an int...ay make some species more aggressive. , Experime...lia,s Great Barrier Reef have shown for the first ...imid, or consistently bold, and that these individ...eratures rise. , A slight lift of just one or tw...
(Date:12/3/2009)...m the U.S. Department of Energy,s (DOE) Brookhaven...Indian Institute of Science has made a major step ...information in DNA that is necessary to carry out ...ished in the December 1, 2009 edition of Nature S... proteins responsible for interacting at specific ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 1Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 1maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 1Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 2Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 4
...f the 2006-2007 activities of UC San Diegos engine...y they recently took home the nations most outstan...oss fundraiser. , Youll find the detailed lesson ...ineering and science fundamentals to 75 fifth grad... find all kinds of information about the tutoring ...
...ajor role in an international scientific team that...ely related fruit fly species. As well has having ...tation to evolving immune systems -- the analysis ...on of each species., From the results of the resea... two papers published this week in the journal Nat...
...y of Idaho researchers are crossing academic and g...ses against Staphylococcus aureus bacteria and oth... effort is to create much faster and more accurate...otic methicillin, formally known as methicillin-re...rough detection technologies are already in hand i...
Other Biology News:UC-San Diego Engineering Honor Society wins most outstanding chapter award 2International team compares 12 fruit fly genomes 2International team compares 12 fruit fly genomes 3Developing kryptonite for Superbug 2Developing kryptonite for Superbug 3Developing kryptonite for Superbug 4Developing kryptonite for Superbug 5
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
UltraClean Microbial DNA Isolation Kit from Mo Bio Laboratories, Inc.
Custom Oligo Assay Single Locus 1920 samples from Illumina
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Biology Products: